Mulligan LM - Search Results

1

Reconsideration of biallelic inactivation of the VHL tumour suppressor gene in hemangioblastomas of the central nervous system.

Gläsker S, Bender BU, Apel TW, van Velthoven V, Mulligan LM, Zentner J, Neumann HP. Gläsker S, et al. Among authors: mulligan lm. J Neurol Neurosurg Psychiatry. 2001 May;70(5):644-8. doi: 10.1136/jnnp.70.5.644. J Neurol Neurosurg Psychiatry. 2001. PMID: 11309459 Free PMC article.

2

Consequences of direct genetic testing for germline mutations in the clinical management of families with multiple endocrine neoplasia, type II.

Neumann HP, Eng C, Mulligan LM, Glavac D, Zäuner I, Ponder BA, Crossey PA, Maher ER, Brauch H. Neumann HP, et al. Among authors: mulligan lm. JAMA. 1995 Oct 11;274(14):1149-51. JAMA. 1995. PMID: 7563486

3

Mutation of the RET protooncogene in sporadic medullary thyroid carcinoma.

Eng C, Mulligan LM, Smith DP, Healey CS, Frilling A, Raue F, Neumann HP, Pfragner R, Behmel A, Lorenzo MJ, et al. Eng C, et al. Among authors: mulligan lm. Genes Chromosomes Cancer. 1995 Mar;12(3):209-12. doi: 10.1002/gcc.2870120308. Genes Chromosomes Cancer. 1995. PMID: 7536460

4

Low frequency of germline mutations in the RET proto-oncogene in patients with apparently sporadic medullary thyroid carcinoma.

Eng C, Mulligan LM, Smith DP, Healey CS, Frilling A, Raue F, Neumann HP, Ponder MA, Ponder BA. Eng C, et al. Among authors: mulligan lm. Clin Endocrinol (Oxf). 1995 Jul;43(1):123-7. doi: 10.1111/j.1365-2265.1995.tb01903.x. Clin Endocrinol (Oxf). 1995. PMID: 7641404

5

Mutation analysis of glial cell line-derived neurotrophic factor, a ligand for an RET/coreceptor complex, in multiple endocrine neoplasia type 2 and sporadic neuroendocrine tumors.

Marsh DJ, Zheng Z, Arnold A, Andrew SD, Learoyd D, Frilling A, Komminoth P, Neumann HP, Ponder BA, Rollins BJ, Shapiro GI, Robinson BG, Mulligan LM, Eng C. Marsh DJ, et al. Among authors: mulligan lm. J Clin Endocrinol Metab. 1997 Sep;82(9):3025-8. doi: 10.1210/jcem.82.9.4197. J Clin Endocrinol Metab. 1997. PMID: 9284737

6

Isolated familial pheochromocytoma as a variant of von Hippel-Lindau disease.

Ritter MM, Frilling A, Crossey PA, Höppner W, Maher ER, Mulligan L, Ponder BA, Engelhardt D. Ritter MM, et al. J Clin Endocrinol Metab. 1996 Mar;81(3):1035-7. doi: 10.1210/jcem.81.3.8772572. J Clin Endocrinol Metab. 1996. PMID: 8772572

7

Mutations in the RET proto-oncogene and the von Hippel-Lindau disease tumour suppressor gene in sporadic and syndromic phaeochromocytomas.

Eng C, Crossey PA, Mulligan LM, Healey CS, Houghton C, Prowse A, Chew SL, Dahia PL, O'Riordan JL, Toledo SP, et al. Eng C, et al. Among authors: mulligan lm. J Med Genet. 1995 Dec;32(12):934-7. doi: 10.1136/jmg.32.12.934. J Med Genet. 1995. PMID: 8825918 Free PMC article.

8

Presymptomatic genetic screening in families with multiple endocrine neoplasia type 2.

Frilling A, Höppner W, Eng C, Mulligan L, Raue F, Broelsch CE. Frilling A, et al. J Mol Med (Berl). 1995 May;73(5):229-33. doi: 10.1007/BF00189922. J Mol Med (Berl). 1995. PMID: 7670926

9

Genetic basis of endocrine disease: multiple endocrine neoplasia type 2.

Mulligan LM, Ponder BA. Mulligan LM, et al. J Clin Endocrinol Metab. 1995 Jul;80(7):1989-95. doi: 10.1210/jcem.80.7.7608246. J Clin Endocrinol Metab. 1995. PMID: 7608246 Review. No abstract available.

10

Genetic events in tumour initiation and progression in multiple endocrine neoplasia type 2.

Mulligan LM, Gardner E, Smith BA, Mathew CG, Ponder BA. Mulligan LM, et al. Genes Chromosomes Cancer. 1993 Mar;6(3):166-77. doi: 10.1002/gcc.2870060307. Genes Chromosomes Cancer. 1993. PMID: 7682102

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

139 results

Search Page

Filters